Search research articles
Contact Us
Filters
Showing results (81-90 of 144) with videos related to
Page
of 15
Sort By:
Journal of Neuroinflammation
|
August 20, 2017
Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease
Lori N Eidson, George T Kannarkat, Christopher J Barnum, et al.
Archives of Neurology
|
April 17, 2008
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease
Michael A Schwarzschild, Steven R Schwid, Kenneth Marek, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 12, 2014
A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study
Caroline M Tanner, Cheryl C Meng, Bernard Ravina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 14, 2014
Individual-reader diagnostic performance and between-reader agreement in assessment of subjects with Parkinsonian syndrome or dementia using 123I-ioflupane injection (DaTscan) imaging
John P Seibyl, Andreas Kupsch, Jan Booij, et al.
Journal of Parkinson'S Disease
|
April 7, 2020
Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson's Disease Research: The Fox Insight Cohort Experience
Roseanne D Dobkin, Ninad Amondikar, Catherine Kopil, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 27, 2016
Abolishing the 1-year rule: How much evidence will be enough?
Ronald B Postuma, Daniela Berg, Matthew Stern, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 13, 2014
Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease
Daniela Berg, Ronald B Postuma, Bastiaan Bloem, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 13, 2019
Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of <sup>18</sup>F-PI-2620 PET for the Assessment of Tau Deposits in the Human Brain
Santiago Bullich, Olivier Barret, Cristian Constantinescu, et al.
Nature Medicine
|
April 15, 2024
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease
Gennaro Pagano, Kirsten I Taylor, Judith Anzures Cabrera, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 30, 2019
[<sup>18</sup>F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease
Sandra Sanabria Bohórquez, Jan Marik, Annie Ogasawara, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 144) with videos related to
Sort By:
Page
of 15
Journal of Neuroinflammation
|
August 20, 2017
Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease
Lori N Eidson, George T Kannarkat, Christopher J Barnum, et al.
Archives of Neurology
|
April 17, 2008
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease
Michael A Schwarzschild, Steven R Schwid, Kenneth Marek, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 12, 2014
A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study
Caroline M Tanner, Cheryl C Meng, Bernard Ravina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 14, 2014
Individual-reader diagnostic performance and between-reader agreement in assessment of subjects with Parkinsonian syndrome or dementia using 123I-ioflupane injection (DaTscan) imaging
John P Seibyl, Andreas Kupsch, Jan Booij, et al.
Journal of Parkinson'S Disease
|
April 7, 2020
Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson's Disease Research: The Fox Insight Cohort Experience
Roseanne D Dobkin, Ninad Amondikar, Catherine Kopil, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 27, 2016
Abolishing the 1-year rule: How much evidence will be enough?
Ronald B Postuma, Daniela Berg, Matthew Stern, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 13, 2014
Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease
Daniela Berg, Ronald B Postuma, Bastiaan Bloem, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 13, 2019
Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of <sup>18</sup>F-PI-2620 PET for the Assessment of Tau Deposits in the Human Brain
Santiago Bullich, Olivier Barret, Cristian Constantinescu, et al.
Nature Medicine
|
April 15, 2024
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease
Gennaro Pagano, Kirsten I Taylor, Judith Anzures Cabrera, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 30, 2019
[<sup>18</sup>F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease
Sandra Sanabria Bohórquez, Jan Marik, Annie Ogasawara, et al.
Page
of 15